India joins the Global AMR R&D Hub
The Global Antimicrobial Resistance (AMR) Research and Development (R&D) Hub is pleased to announce that India has joined the Hub as a new Member. This expands the global partnership working to address challenges and improve coordination and collaboration in global AMR R&D to 16 countries, the European Commission, two philanthropic foundations and four international organisations (as observers).
The Global AMR R&D Hub was launched in May 2018 in the margins of the 71st session of the World Health Assembly, following a call from G20 Leaders in 2017. The Global AMR R&D Hub supports global priority setting and evidence‐based decision‐making on the allocation of resources for AMR R&D through the identification of gaps, overlaps and potential for cross‐sectoral collaboration and leveraging in AMR R&D. The operation of the Global AMR R&D Hub is supported through a Secretariat, established in Berlin under the roof of the Deutsches Zentrum für Infektionsforschung (DZIF) and currently financed through grants from the German Federal Ministry of Education and Research (BMBF) and the Federal
Ministry of Health (BMG).
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Evotec |
 |
JSS University |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
Technology Database
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.
